Bachmann Katherine Neubecker, Fazeli Pouneh K, Lawson Elizabeth A, Russell Brian M, Riccio Ariana D, Meenaghan Erinne, Gerweck Anu V, Eddy Kamryn, Holmes Tara, Goldstein Mark, Weigel Thomas, Ebrahimi Seda, Mickley Diane, Gleysteen Suzanne, Bredella Miriam A, Klibanski Anne, Miller Karen K
Neuroendocrine Unit (K.N.B., P.K.F., E.A.L., A.K., K.K.M.), Departments of Psychiatry (K.E.) and Radiology (M.A.B.), Massachusetts General Hospital and Harvard Medical School, and Neuroendocrine Unit (B.M.R., A.D.R., E.M., A.V.G.), Clinical Research Center (T.H.), Massachusetts General Hospital, and Division of Adolescent Medicine (M.G.), Massachusetts General Hospital for Children and Harvard Medical School, Boston, Massachusetts 02114; Klarman Center (T.W.), McLean Hospital and Harvard Medical School, Belmont, Massachusetts 02478; Cambridge Eating Disorders Center (S.E.), Cambridge, Massachusetts 02138; Wilkins Center for Eating Disorders (D.M.), Greenwich, Connecticut 06831; and Beth Israel Deaconess Medical Center (S.G.) and Harvard Medical School, Boston, Massachusetts 02446.
J Clin Endocrinol Metab. 2014 Dec;99(12):4664-73. doi: 10.1210/jc.2014-2104.
Data suggest that anorexia nervosa (AN) and obesity are complicated by elevated fracture risk, but skeletal site-specific data are lacking. Traditional bone mineral density (BMD) measurements are unsatisfactory at both weight extremes. Hip structural analysis (HSA) uses dual-energy X-ray absorptiometry data to estimate hip geometry and femoral strength. Factor of risk (φ) is the ratio of force applied to the hip from a fall with respect to femoral strength; higher values indicate higher hip fracture risk.
The objective of the study was to investigate hip fracture risk in AN and overweight/obese women.
This was a cross-sectional study.
The study was conducted at a Clinical Research Center.
PATIENTS included 368 women (aged 19-45 y): 246 AN, 53 overweight/obese, and 69 lean controls.
HSA-derived femoral geometry, peak factor of risk for hip fracture, and factor of risk for hip fracture attenuated by trochanteric soft tissue (φ(attenuated)) were measured.
Most HSA-derived parameters were impaired in AN and superior in obese/overweight women vs controls at the narrow neck, intertrochanteric, and femoral shaft (P ≤ .03). The φ(attenuated) was highest in AN and lowest in overweight/obese women (P < .0001). Lean mass was associated with superior, and duration of amenorrhea with inferior, HSA-derived parameters and φ(attenuated) (P < .05). Mean φ(attenuated) (P = .036), but not femoral neck BMD or HSA-estimated geometry, was impaired in women who had experienced fragility fractures.
Femoral geometry by HSA, hip BMD, and factor of risk for hip fracture attenuated by soft tissue are impaired in AN and superior in obesity, suggesting higher and lower hip fracture risk, respectively. Only attenuated factor of risk was associated with fragility fracture prevalence, suggesting that variability in soft tissue padding may help explain site-specific fracture risk not captured by BMD.
数据表明神经性厌食症(AN)和肥胖症会因骨折风险升高而变得复杂,但缺乏骨骼部位特异性数据。传统的骨密度(BMD)测量在两种体重极端情况下都不尽人意。髋部结构分析(HSA)利用双能X线吸收法数据来估计髋部几何形状和股骨强度。风险因子(φ)是跌倒时作用于髋部的力与股骨强度的比值;数值越高表明髋部骨折风险越高。
本研究的目的是调查AN和超重/肥胖女性的髋部骨折风险。
这是一项横断面研究。
该研究在一个临床研究中心进行。
患者包括368名女性(年龄19 - 45岁):246名患AN,53名超重/肥胖,69名瘦对照组。
测量HSA得出的股骨几何形状、髋部骨折的峰值风险因子以及经转子软组织衰减后的髋部骨折风险因子(φ(衰减))。
在狭窄颈部、转子间和股骨干处,大多数HSA得出的参数在AN中受损,在肥胖/超重女性中优于对照组(P≤0.03)。φ(衰减)在AN中最高,在超重/肥胖女性中最低(P<0.0001)。瘦体重与较好的HSA得出的参数和φ(衰减)相关,闭经持续时间则与之相反(P<0.05)。经历过脆性骨折的女性的平均φ(衰减)受损(P = 0.036),但股骨颈BMD或HSA估计的几何形状未受损。
HSA得出的股骨几何形状、髋部BMD以及经软组织衰减后的髋部骨折风险因子在AN中受损,在肥胖中较好,分别表明较高和较低的髋部骨折风险。只有衰减后的风险因子与脆性骨折患病率相关,这表明软组织填充的差异可能有助于解释BMD未捕捉到的部位特异性骨折风险。